[go: up one dir, main page]

CY1105849T1 - Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος - Google Patents

Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος

Info

Publication number
CY1105849T1
CY1105849T1 CY20061101794T CY061101794T CY1105849T1 CY 1105849 T1 CY1105849 T1 CY 1105849T1 CY 20061101794 T CY20061101794 T CY 20061101794T CY 061101794 T CY061101794 T CY 061101794T CY 1105849 T1 CY1105849 T1 CY 1105849T1
Authority
CY
Cyprus
Prior art keywords
treatment
antiseptics
inflammation
prevention
human body
Prior art date
Application number
CY20061101794T
Other languages
English (en)
Inventor
Wolfgang Dr. Fleischer
Karen Reimer
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of CY1105849T1 publication Critical patent/CY1105849T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Χρήση αντιφλεγμονώδους παράγοντα, όπως η ιωδιούχος ποβιδόνη προς παρασκευή μίας φαρμακευτικής σύνθεσης στην αγωγή έναντι ασθενειών εκδηλωμένες στο εσωτερικό του σώματος του ανθρώπου ή ζώων και οι οποίες είναι ευεπηρέαστες από τη χορήγηση τέτοιων παραγόντων.
CY20061101794T 1999-05-27 2006-12-13 Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος CY1105849T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19924313 1999-05-27
EP00936804A EP1180018B1 (en) 1999-05-27 2000-05-25 Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention and treatment of infections and/ or functional tissue remodelling in the interior of the human body

Publications (1)

Publication Number Publication Date
CY1105849T1 true CY1105849T1 (el) 2011-02-02

Family

ID=7909362

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101794T CY1105849T1 (el) 1999-05-27 2006-12-13 Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος

Country Status (20)

Country Link
US (1) US7468194B1 (el)
EP (2) EP1180018B1 (el)
JP (1) JP5616565B2 (el)
KR (1) KR100687781B1 (el)
CN (1) CN1197552C (el)
AT (2) ATE289805T1 (el)
AU (1) AU772314B2 (el)
BR (1) BR0010983A (el)
CA (1) CA2368192A1 (el)
CY (1) CY1105849T1 (el)
DE (3) DE60031016T2 (el)
DK (1) DK1502586T3 (el)
ES (2) ES2235891T3 (el)
HK (1) HK1046242B (el)
HU (1) HU229598B1 (el)
IL (2) IL146133A0 (el)
MX (1) MXPA01012170A (el)
PT (1) PT1502586E (el)
RU (1) RU2264827C2 (el)
WO (1) WO2000072823A1 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9911072A (pt) * 1998-05-27 2001-02-06 Euro Celtique Sa Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépicos e/ou agentes promotores da cura de feridas no trato respiratório inferior
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
ES2292874T3 (es) 2003-05-19 2008-03-16 Euro-Celtique S.A. Composiciones liposomales secas de pvp-yodo.
DE102005063375A1 (de) * 2005-09-15 2007-04-19 Schülke & Mayr GmbH Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
US8906966B2 (en) 2006-07-13 2014-12-09 Paul Sherwood Medicaments containing panthenol
EP2178526A1 (en) * 2007-07-13 2010-04-28 Prototype Bioforum Limited Injectable pharmaceutical compositions containing panthenol
CN101987109B (zh) * 2009-08-05 2012-07-04 天津金耀集团有限公司 含有聚维酮碘与环糊精包合糖皮质激素的眼用组合物
CN102429862B (zh) * 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液
CN103143053A (zh) * 2013-03-24 2013-06-12 山东康力医疗器械科技有限公司 新型聚维酮碘抗菌水胶体敷料及其制备方法
CN104147610A (zh) * 2014-06-26 2014-11-19 中国人民解放军第三○九医院 一种附载抗菌成分的高分子微纳米粒及其制备方法
CN106307543B (zh) * 2016-08-22 2020-02-07 青岛农业大学 一种麝香草酚纳米脂质体及其制备方法
CN109180600A (zh) * 2018-09-21 2019-01-11 五邑大学 一种麝香草酚类似物及其应用
CN111329824A (zh) * 2020-04-02 2020-06-26 东元科技有限公司 一种杀菌能力强的洗手消毒剂
US11590056B2 (en) * 2020-07-30 2023-02-28 Sartorius Stedim North America Freeze/thaw containment system for flexible pouch filled with biopharmaceutical fluid, and method of assembling a freeze/thaw containment system, using a protecting body

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615889A (el) 1952-04-15 1900-01-01
US4113857A (en) 1977-05-16 1978-09-12 The Purdue Frederick Company Process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing the same
US4675009A (en) 1977-11-07 1987-06-23 Lec Tec Corporation Drug dispensing device for transdermal delivery of medicaments
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
FR2536278A1 (fr) 1982-11-18 1984-05-25 Dupont Michele Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies
US4523589A (en) * 1983-06-29 1985-06-18 Krauser Robert S Method and apparatus for treating ailments
FR2591105B1 (fr) 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
SE8603812D0 (sv) 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
IE63869B1 (en) * 1986-11-06 1995-06-14 Res Dev Foundation Aerosols containing liposomes and method for their preparation
US5049388A (en) 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
JPH0761940B2 (ja) 1986-11-17 1995-07-05 株式会社資生堂 外皮用リポソ−ム製剤
CH672733A5 (el) 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
US4938965A (en) 1987-07-22 1990-07-03 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Ocular delivery of prophylactic agents
US5246708A (en) 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
CA1303503C (en) 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
ZA892928B (en) * 1988-04-25 1991-01-30 Pro Neuron Inc Pharmaceutical compositions containing deoxyribonucleosides for wound healing
DE3826946C1 (el) 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
US4906476A (en) 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
JPH02204413A (ja) 1989-02-02 1990-08-14 Nonogawa Shoji:Kk 抗真菌外用製剤
IL93996A0 (en) 1989-04-04 1991-01-31 Alcon Lab Inc Pharmaceutical composition containing a liposome
US5232692A (en) 1989-04-28 1993-08-03 Research And Education Institute, Inc. Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent
EP0407028B2 (en) 1989-05-31 1999-07-07 FISONS plc Medicament inhalation device and formulation
RU2123338C1 (ru) * 1990-06-15 1998-12-20 Сайтел Корпорейшн Фармацевтическая композиция на основе медиатора межклеточной адгезии (варианты), способ ингибирования межклеточной адгезии, способ лечения воспалительного заболевания, способ анализа тестируемого соединения на способность ингибировать клеточную адгезию, способ получения соединения
US5128139A (en) 1991-02-15 1992-07-07 Nu Skin International, Inc. Composition containing liposome-entrapped grapefruit seed extract and method for making
DE4111982C2 (de) 1991-04-12 1998-12-24 Merz & Co Gmbh & Co Stabile kleinpartikuläre Liposomenzubereitungen, deren Herstellung und Verwendung
EP0580860B2 (en) 1991-04-16 2004-12-15 Nippon Shinyaku Company, Limited Method of manufacturing solid dispersion
ATE221379T1 (de) 1991-05-01 2002-08-15 Jackson H M Found Military Med Verfahren zur behandlung infektiöser respiratorischer erkrankungen
DK0642366T3 (da) 1992-05-29 1998-07-20 Ggu Ges F R Gesundheits Und Um Anordning til frembringelse af inhalerbare aktivepartikler
CA2097163C (en) * 1992-06-01 2002-07-30 Marianna Foldvari Topical patch for liposomal drug delivery system
WO1994014490A1 (de) 1992-12-23 1994-07-07 Bernhard Hugemann Verfestigter arzneistoffvorrat für die mechanische erzeugung inhalierbarer wirkstoffpartikel
US5552158A (en) 1993-02-23 1996-09-03 Norac Technologies Inc. Skin care composition
DE4306475A1 (de) 1993-03-02 1994-09-08 Ensenat Pedro Gonzalez Liposomen, enthaltend Chlorhexidindiacetat oder Chlorhexidindigluconat
US5270307A (en) 1993-03-26 1993-12-14 The Dow Chemical Company Pyrrolo(1,2-b)-(1,2)-benzothiazin-10-one and its use as an antimicrobial
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
DE9312509U1 (de) 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
BR9509590A (pt) * 1994-11-04 1997-12-23 Polymun Scient Immunbio Forsch Aplicação de sod em liposomas
US6103706A (en) * 1997-04-29 2000-08-15 New York Blood Center, Inc. Methods for treating viral infections
AU7454698A (en) 1997-06-06 1998-12-21 Shionogi & Co., Ltd. Improvement in medicament administration system
BR9911072A (pt) 1998-05-27 2001-02-06 Euro Celtique Sa Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépicos e/ou agentes promotores da cura de feridas no trato respiratório inferior

Also Published As

Publication number Publication date
KR20020012234A (ko) 2002-02-15
US7468194B1 (en) 2008-12-23
EP1502586A1 (en) 2005-02-02
HK1046242B (zh) 2005-08-12
ES2274372T3 (es) 2007-05-16
EP1180018B1 (en) 2005-03-02
CN1352551A (zh) 2002-06-05
DE60031016D1 (de) 2006-11-09
DE60018409T2 (de) 2005-12-29
EP1502586B1 (en) 2006-09-27
HK1073252A1 (en) 2005-09-30
DE60031016T2 (de) 2007-05-16
JP2003500436A (ja) 2003-01-07
HUP0201038A3 (en) 2003-04-28
RU2001135842A (ru) 2003-08-20
CA2368192A1 (en) 2000-12-07
AU772314B2 (en) 2004-04-22
WO2000072823A8 (en) 2001-06-07
IL146133A0 (en) 2002-07-25
DE20022718U1 (de) 2002-04-04
KR100687781B1 (ko) 2007-02-28
HU229598B1 (en) 2014-02-28
RU2264827C2 (ru) 2005-11-27
ES2235891T3 (es) 2005-07-16
DE60018409D1 (de) 2005-04-07
ATE289805T1 (de) 2005-03-15
WO2000072823A1 (en) 2000-12-07
ATE340561T1 (de) 2006-10-15
HK1046242A1 (en) 2003-01-03
DK1502586T3 (da) 2007-02-05
EP1180018A1 (en) 2002-02-20
MXPA01012170A (es) 2002-06-21
JP5616565B2 (ja) 2014-10-29
HUP0201038A2 (en) 2002-09-28
AU5216600A (en) 2000-12-18
PT1502586E (pt) 2007-01-31
CN1197552C (zh) 2005-04-20
IL146133A (en) 2006-12-31
BR0010983A (pt) 2002-03-05

Similar Documents

Publication Publication Date Title
CY1105834T1 (el) Χρηση παρασκευασματων για την εφαρμογη, στον κατω αναπνευστικο σωληνα αντισηπτικων παραγοντων και/ή παραγοντων που προαγουν την επουλωση των πληγων
CY1105849T1 (el) Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος
CY1112753T1 (el) Θεραπευτικη αγωγη καρκινων του ανθρωπινου σωματος με τη χρηση toy ετ743
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
CY1108601T1 (el) Τοπικη φαρμακοτεχνικη μορφη που περιλαμβανει τουλαχιστον 10% μετρονιδαζολης σε βαζελινη καιχρηση αυτης στην πρωκτικη και ορθικη περιοχη
BRPI0412211A (pt) composições de liberação controlada
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
ES2171933T3 (es) Derivados de androsteno.
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
CY1110078T1 (el) Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
TR200002969T2 (tr) Farmasötik bileşim.
BRPI0415755A (pt) antagonistas do receptor b1 de bradiquinina
CY1108004T1 (el) Χρηση r-αρυλοπροπιονικων οξεων για την παραγωγη φαρμακων για την αντιμετωπιση παθησεων σε ανθρωπους και ζωα, οι οποιες μπορουν να επηρεαστουν θepαπευτικα μεσω της αναστολης της ενepγοποιησης του nf-kb
SE9700934D0 (sv) New formulation
ATE390124T1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
ATE454139T1 (de) Arzneimittel mit shikonin als wirkstoff
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
AR022348A1 (es) Una composicion farmaceutica para el tratamiento de los sintomas del tracto urinario inferior
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
ITBO990038A0 (it) Pomata per la cura delle lesioni cutanee particolarmente delle ustioni .
IT1307235B1 (it) Derivati del peg e loro impiego per la preparazione di coniugati diinteresse terapeutico.
ITBG990061A0 (it) Unguento ad azione terapeutica ed antisettica del derma animale, particolarmente a localizzazione podalica.